Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...
Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled device that recommends personalized comfort settings to help people with obst ...
CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and ...
ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...
Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart ...
As infections from the ongoing COVID-19 pandemic continue to climb, hospitals around the world are struggling with a potentially fatal shortage of ventilators, the bedside machines that help patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback